ExodusPoint Capital Management’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-177,072
| Closed | -$4.18M | – | 1956 |
|
|
2023
Q4 | $4.18M | Buy |
177,072
+163,441
| +1,199% | +$3.86M | 0.03% | 346 |
|
|
2023
Q3 | $203K | Buy |
+13,631
| New | +$203K | ﹤0.01% | 1477 |
|
|
2022
Q3 | – | Sell |
-13,535
| Closed | -$40K | – | 2344 |
|
|
2022
Q2 | $40K | Sell |
13,535
-26,690
| -66% | -$78.9K | ﹤0.01% | 1760 |
|
|
2022
Q1 | $125K | Buy |
40,225
+4,730
| +13% | +$14.7K | ﹤0.01% | 1916 |
|
|
2021
Q4 | $120K | Buy |
+35,495
| New | +$120K | ﹤0.01% | 1883 |
|
|
2021
Q3 | – | Sell |
-28,719
| Closed | -$125K | – | 2704 |
|
|
2021
Q2 | $125K | Buy |
28,719
+10,980
| +62% | +$47.8K | ﹤0.01% | 2028 |
|
|
2021
Q1 | $81K | Buy |
+17,739
| New | +$81K | ﹤0.01% | 1952 |
|
|
2020
Q4 | – | Sell |
-19,971
| Closed | -$145K | – | 2390 |
|
|
2020
Q3 | $145K | Sell |
19,971
-72,021
| -78% | -$523K | ﹤0.01% | 1494 |
|
|
2020
Q2 | $321K | Buy |
+91,992
| New | +$321K | 0.01% | 1266 |
|
|
2019
Q3 | – | Sell |
-18,142
| Closed | -$130K | – | 1672 |
|
|
2019
Q2 | $130K | Sell |
18,142
-35,861
| -66% | -$257K | 0.01% | 972 |
|
|
2019
Q1 | $717K | Buy |
+54,003
| New | +$717K | 0.05% | 240 |
|